Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.1

(2.01%)

FLWS

$4.31

(-0.23%)

ACCO

(0.38%)

ARLP

$25.46

(0.34%)

AUIAF

$0.14

(0.07%)

AZZ

$141.13

(-2.11%)

BTBT

$1.71

(-2.84%)

BTM

$0.49

(0%)

CVKD

$4.2

(6.33%)

LCE:CA

$0.31

(3.33%)

COCP

$1.01

(-0.98%)

CDRO

$9.69

(-0.1%)

CVGI

$4.95

(-4.07%)

LODE

$3.73

(-2.99%)

CMTL

$4.22

(0.96%)

CNDT

$1.4

(-0.71%)

CXW

$25.54

(1.43%)

CMLS

$0.01

(0%)

DRCT

$2.9

(0.87%)

DLHC

$5.59

(0.56%)

SSP

$3.27

(-3.4%)

ELDN

$3.48

(-2.01%)

EVC

$9.24

(0.65%)

EDRY

$21.96

(-1.39%)

ESEA

$66.99

(-0.13%)

FAT

$0.16

(0%)

RAIL

$8.33

(0.12%)

GDEV

$12.88

(-3.95%)

GOVX

$1.27

(-0.78%)

GOCO

$0.3

(-6.23%)

GHM

$95.32

(-4.95%)

GLDD

$17

(0%)

GYRE

$7.58

(-1.88%)

HMENF

$2.02

(1%)

III

$4.29

(1.78%)

IPOOF

$12.25

(2.85%)

KELYA

$11.85

(1.15%)

KTOS

$54.99

(-2.13%)

LUCK

$8.45

(6.63%)

MAIA

$1.34

(3.46%)

MGROF

$0.35

(0%)

NTRB

$3.51

(-0.57%)

OCGN

$1.2

(-3.23%)

PERF

$1.7

(0.59%)

QMCI

$0.16

(0%)

RGP

$4.72

(0.75%)

SGA

$8.95

(0.67%)

SHWZ

(9900%)

SHIP

$15.49

(0.53%)

SLQT

$0.86

(0.57%)

SKYX

$0.98

(-2.97%)

SNAL

$0.75

(-4.4%)

GEO

$27.11

(0.3%)

ODP

$28

(0%)

TNXP

$11.8

(2.97%)

TSQ

$6.59

(0.61%)

TZOO

$10.14

(-0.1%)

UNCY

$7.79

(7.15%)

VVX

$86.91

(1.63%)

VNCE

$4.4

(-0.9%)

XELB

$1.81

(-13.71%)

ZOMDF

$0.1

(2.01%)

FLWS

$4.31

(-0.23%)

channelchek-in

‌

6/10/2026

GSK Pays $10.6 Billion for Nuvalent in Its Largest Acquisition in Over a Decade

The biotech acquisition market just recorded one of its most significant transactions of 2026. GSK (LSE/NYSE: GSK) announced Tuesday it has entered into a definitive agreement to acquire Nuvalent Inc. (Nasdaq: NUVL), a Cambridge, Massachusetts-based clinical-stage biopharmaceutical company focused on precision oncology, for $10.6 billion in an all-cash tender offer at $124 per share. The price represents a 40% premium to Nuvalent’s last closing price and a 26% premium to its 30-day volume-weighted average price. Net of cash acquired, GSK’s aggregate investment is approximately $9.4 billion.

3 min read